LIQUID PHARMACEUTICAL COMPOSITION
The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diab...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NAGEL, Norbert MEYER, Nino KAMM, Walter BAUMGARTNER, Bruno VENCZEL, Marta |
| description | The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
La présente invention concerne une composition pharmaceutique liquide comprenant un peptide de SEQ ID No : 2 utilisé comme principe pharmaceutique actif. La composition de la présente invention est appropriée pour être utilisée à des fins médicales chez l'homme, par exemple dans le traitement de troubles d'un syndrome métabolique ou du diabète ou de l'obésité ou pour la réduction d'une prise alimentaire excessive. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2019122109A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2019122109A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2019122109A13</originalsourceid><addsrcrecordid>eNrjZFD08QwM9XRRCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoaWhkZGhgaWjobGxKkCALd-I00</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LIQUID PHARMACEUTICAL COMPOSITION</title><source>esp@cenet</source><creator>NAGEL, Norbert ; MEYER, Nino ; KAMM, Walter ; BAUMGARTNER, Bruno ; VENCZEL, Marta</creator><creatorcontrib>NAGEL, Norbert ; MEYER, Nino ; KAMM, Walter ; BAUMGARTNER, Bruno ; VENCZEL, Marta</creatorcontrib><description>The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
La présente invention concerne une composition pharmaceutique liquide comprenant un peptide de SEQ ID No : 2 utilisé comme principe pharmaceutique actif. La composition de la présente invention est appropriée pour être utilisée à des fins médicales chez l'homme, par exemple dans le traitement de troubles d'un syndrome métabolique ou du diabète ou de l'obésité ou pour la réduction d'une prise alimentaire excessive.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190627&DB=EPODOC&CC=WO&NR=2019122109A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190627&DB=EPODOC&CC=WO&NR=2019122109A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NAGEL, Norbert</creatorcontrib><creatorcontrib>MEYER, Nino</creatorcontrib><creatorcontrib>KAMM, Walter</creatorcontrib><creatorcontrib>BAUMGARTNER, Bruno</creatorcontrib><creatorcontrib>VENCZEL, Marta</creatorcontrib><title>LIQUID PHARMACEUTICAL COMPOSITION</title><description>The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
La présente invention concerne une composition pharmaceutique liquide comprenant un peptide de SEQ ID No : 2 utilisé comme principe pharmaceutique actif. La composition de la présente invention est appropriée pour être utilisée à des fins médicales chez l'homme, par exemple dans le traitement de troubles d'un syndrome métabolique ou du diabète ou de l'obésité ou pour la réduction d'une prise alimentaire excessive.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD08QwM9XRRCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoaWhkZGhgaWjobGxKkCALd-I00</recordid><startdate>20190627</startdate><enddate>20190627</enddate><creator>NAGEL, Norbert</creator><creator>MEYER, Nino</creator><creator>KAMM, Walter</creator><creator>BAUMGARTNER, Bruno</creator><creator>VENCZEL, Marta</creator><scope>EVB</scope></search><sort><creationdate>20190627</creationdate><title>LIQUID PHARMACEUTICAL COMPOSITION</title><author>NAGEL, Norbert ; MEYER, Nino ; KAMM, Walter ; BAUMGARTNER, Bruno ; VENCZEL, Marta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2019122109A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NAGEL, Norbert</creatorcontrib><creatorcontrib>MEYER, Nino</creatorcontrib><creatorcontrib>KAMM, Walter</creatorcontrib><creatorcontrib>BAUMGARTNER, Bruno</creatorcontrib><creatorcontrib>VENCZEL, Marta</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NAGEL, Norbert</au><au>MEYER, Nino</au><au>KAMM, Walter</au><au>BAUMGARTNER, Bruno</au><au>VENCZEL, Marta</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LIQUID PHARMACEUTICAL COMPOSITION</title><date>2019-06-27</date><risdate>2019</risdate><abstract>The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
La présente invention concerne une composition pharmaceutique liquide comprenant un peptide de SEQ ID No : 2 utilisé comme principe pharmaceutique actif. La composition de la présente invention est appropriée pour être utilisée à des fins médicales chez l'homme, par exemple dans le traitement de troubles d'un syndrome métabolique ou du diabète ou de l'obésité ou pour la réduction d'une prise alimentaire excessive.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2019122109A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | LIQUID PHARMACEUTICAL COMPOSITION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A22%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NAGEL,%20Norbert&rft.date=2019-06-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2019122109A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |